MaxCyte
MXCT
MXCT
114 hedge funds and large institutions have $269M invested in MaxCyte in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 50 increasing their positions, 38 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
-9
Holders Change %
-7.32%
% of All Funds
1.66%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
9
Increased
50
Reduced
38
Closed
17
Calls
$8K
Puts
$14K
Net Calls
-$6K
Net Calls Change
-$14K
Top Buyers
| 1 |
Morgan Stanley
New York
|
$18.2M |
| 2 |
CCM
Cadian Capital Management
New York
|
$29.9M |
| 3 |
BlackRock
New York
|
$31.9M |
| 4 |
MA
Mudita Advisors
London,
United Kingdom
|
$11.7M |
| 5 |
Marshall Wace
London,
United Kingdom
|
$1.96M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Russell Investments Group
London,
United Kingdom
| – | -$28.1K | -6,700 | Closed |
|
|
MLICM
127
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$21.1K | -5,026 | Closed |
|
|
SPIA
128
Steward Partners Investment Advisory
New York
| – | -$6.83K | -1,630 | Closed |
|
|
AWM
129
Avior Wealth Management
Omaha,
Nebraska
| – | -$71 | -17 | Closed |
|